. Author manuscript; available in PMC: 2018 Dec 1.

Published in final edited form as: Dev Psychopathol. 2017 Dec;29(5):1795–1806. doi: 10.1017/S0954579417001407

Table 2.

Maltreatment and NR3C1 methylation

	Mal n=285	Nonmal n=249	Test statistic	Nonmal n=244	EO mal n=121	LO mal n=160	Test statistic	Significant Bonferroni contrasts
NR3C1 mean	−4.55 (.02)	−4.63 (.02)	F (1) = 5.58^*	−4.63 (.02)	−4.50 (.03)	−4.60 (.03)	F (2) = 5.63^**	Nonmal<EO
cg04111177	−4.08 (.01)	−4.07 (.02)	F (1) = .62	−4.07 (.02)	−4.05 (.02)	−4.11 (.02)	F (2) = 2.71^†	--
cg15910486	−3.25 (.02)	−3.32 (.02)	F (1) = 4.53^*	−3.31 (.02)	−3.30 (.03)	−3.22 (.03)	F (2) = 3.96^*	Nonmal<LO
cg18068240	−6.37 (.05)	−6.56 (.06)	F (1) = 6.16^*	−6.56 (.06)	−6.16 (.08)	−6.51 (.07)	F (2) = 8.63^***	Nonmal<EO, LO<EO

Notes: Mal=maltreated, Nonmal=nonmaltreated, EO mal= early onset maltreated, LO mal= late onset maltreated. Means are presented with standard errors in parentheses.

^†

p=.07,

p<.05,

^**

p<.01,

^***

p<.001